Navigation Links
Paracheck Pf (P. falciparum) Rapid Test (Dipstick)

ProductsParacheck Pf (P. falciparum) Rapid Test (Dipstick)
Company Orchid Biomedical Systems
Item Paracheck Pf (P. falciparum) Rapid Test (Dipstick)
Features 
  • Paracheck Pf is a test for the detection of P. falciparum malaria that utilizes the principle of immunochromatography
  • As the test sample flows through the membrane assembly of the dipstick after placing into the clearing buffer tube, the colored anti Pf HRP-2 antisera-colloidal gold conjugate (monoclonal) complexes the Pf HRP-2 in the lysed sample
  • This complex moves further on the membrane to the test region where it is immobilised by the anti Pf HRP-2 (monoclonal) antisera coated on the membrane leading to formation of a pink colored band which confirms a positive test result
  • Absence of this colored band in the test region indicates a negative test result
  • A control band serves to validate the test performance
Description Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples.
Info Orchid Biomedical Systems
Customer Service: (0832) 2437610/11
Web site: http://www.tulipgroup.com/Orchid/

Related medicine products :

1. RapidLab 248 Blood Gas Analyzer
2. Rapidlab 800 System
3. Rapidlab 348 Blood Gas Analyzer
4. Rapidpoint 400
5. Rapidlink Critical Care Information Management System
6. IDS Rapid NF Plus
7. IDS Rapid NH
8. IDS Rapid One
9. IDS Rapid SS/u
10. IDS Rapid STR
11. IDS Rapid Yeast Plus
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
...ARUP Laboratories is a national reference laborato... research and development. ARUP offers an extensiv...ests in clinical and anatomic pathology. Owned by ... include more than half of the nation's university...
Medicine Products:
(Date:11/21/2008)...l/ -- Heska Corporation,(Nasdaq: HSKA ) today a...f,Security Analysts, 12th Annual Biotech and Spec...77 Avenue of the Americas, 2nd Floor in New York, ...5 a.m. Eastern Time (7:35 a.m.,Mountain Time) and...eks,following the presentation through a link und...
(Date:11/21/2008)... Lennox-Gastaut syndrome , , FRIDAY, Nov...(rufinamide) has been approved as a supplementary ...nox-Gastaut syndrome, the U.S. Food and Drug Admin...based on results of a four-month clinical trial th...ients who took a placebo, those who took the drug ...
(Date:11/21/2008)...Center.com, the premier site,for online nursing c... been,updated to improve the interactive experien...ippincott Williams & Wilkins (LWW), NursingCen...nuing education activities and free,access to 11,...rnals.,Lippincott Williams & Wilkins is a par...
(Date:11/21/2008)...stCall/ -- Today, prescription drugs are the first...rcent of patients suffering chronic conditions. T...ondition account for 96 percent of all prescriptio...s. A proprietary new pharmacy model developed ove...E: MHS ) significantly reduces critical gaps in ...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6
... and dental hygienists as lifesavers, but Dr. Gwen...ant professor of dental// hygiene at New York City...to routinely conduct periodontal evaluations and o...s well as how to recognize the clinical signs of s...
... cells from the lungs of transplant patients demon...ells //reside in adult organs and are not derived ...hat the cells may be able to help with the rejecti...kinds of lung disease. The study by University of...
...and the Medicines for Malaria Venture plan to fund...nited Arab Emirates (UAE). The center will focus o...Gulf News reports. Gates Foundation and MMV repre...ials from the UAE Ministry of Health to discuss th...
...e parents of Canada’s conjoined twins and to the p...have confirmed //after days of several tests that ...ined twins, known by the names Krista and Tatiana ...eads joined. The twins, who are four months of age...
Other Medicine News:Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 2Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 3Health News:Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease 4Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 2Health News:Stem Cell Finding Could Help Reduce Transplant Rejection 3
(Date:11/19/2008)... N.Y., Nov. 19 Biotech scientists ... toxicology research to better understand the effe... systems, reports Genetic Engineering & Biote...sted in figuring out a new compound,s mechanism of...icology technique, according to the November 15 is...
(Date:11/18/2008)...ristmasseals.org to learn more, make a donation o...TON, Nov. 17 Millions w..., courtesy of the American Lung Association. These...undraising tradition dating back to 1907 when the ...is. , , "Most Americans alive today have ...
(Date:11/18/2008)...udy will enroll newly diagnosed, elderly AML patie...e/ -- Celator Pharmaceuticals today announced that...d Phase 2 clinical study of CPX-351 (Cytarabine:Da...wly diagnosed acute myeloid leukemia (AML). , ...n, MD at the Weill Medical College of Cornell Uni...
(Date:11/12/2008)... Nov. 12 A new study be...ell will help answer the,question, what causes Par...ions in the medical research into,Parkinson,s dise...n to die,in the first place. Answering this questi... two nearly identical types of brain cells that pr...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 2Celator(R) Pharmaceuticals Announces Enrollment of First Patient in Phase 2 Study with CPX-351 3A Window Into Parkinson's Disease 2Kissing cousins 559 1Kissing cousins 559 2With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 1With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 2With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 3With the Largest Ever Buyout of a National Nursing Home Chain Pending New York Times Exposes Harm to Seniors After Private Equity Buyouts of Nursi 1996 4Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 1992 1Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 1992 2Randolph Equities to Break Ground on State of the Art Medical Center in Space Starved Near West Chicago Suburbs 1992 3Abbott Initiates Clinical Study to Evaluate Use of RX Herculink 28R 29 Elite 28TM 29 Renal Stent System for the Treatment of Renal Artery Stenosis 381 1Abbott Initiates Clinical Study to Evaluate Use of RX Herculink 28R 29 Elite 28TM 29 Renal Stent System for the Treatment of Renal Artery Stenosis 381 2Abbott Initiates Clinical Study to Evaluate Use of RX Herculink 28R 29 Elite 28TM 29 Renal Stent System for the Treatment of Renal Artery Stenosis 381 3
...7 - AVI BioPharma, Inc.,(Nasdaq:AVII) announced to...rget patient enrollment and released six-month,fol...s Appraisal.,The trial, currently being held in Ge...gene(R) antisense drug Resten-MP(TM), when,used in...e metal,stents, in the prevention of cardiovascula...
...cebo Adjusted Weight,Loss; Obesity Program to be D...irstCall/ -- Manhattan,Pharmaceuticals, Inc. today...linical trials of oral Oleoyl-estrone (OE). The re...ntrolled studies, one,in common obesity and the ot...ly or clinically meaningful placebo adjusted weigh...
Other Medicine Technology:AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4